Cargando…

Alzheimer’s Disease Animal Models: Elucidation of Biomarkers and Therapeutic Approaches for Cognitive Impairment

Alzheimer’s disease (AD) is an age-related and progressive neurodegenerative disorder. It is widely accepted that AD is mainly caused by the accumulation of extracellular amyloid β (Aβ) and intracellular neurofibrillary tau tangles. Aβ begins to accumulate years before the onset of cognitive impairm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nakai, Tsuyoshi, Yamada, Kiyofumi, Mizoguchi, Hiroyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8197360/ https://www.ncbi.nlm.nih.gov/pubmed/34074018 http://dx.doi.org/10.3390/ijms22115549

Ejemplares similares

Matrix Metalloproteinases Contribute to Neuronal Dysfunction in Animal Models of Drug Dependence, Alzheimer's Disease, and Epilepsy
por: Mizoguchi, Hiroyuki, et al.
Publicado: (2011)

Pharmacologic Treatment with GABA(B) Receptor Agonist of Methamphetamine-Induced Cognitive Impairment in Mice
por: Mizoguchi, Hiroyuki, et al.
Publicado: (2011)

New Strategies for the Treatment of Neuropsychiatric Disorders Based on Reelin Dysfunction
por: Tsuneura, Yumi, et al.
Publicado: (2022)

Roles of Matrix Metalloproteinases and Their Targets in Epileptogenesis and Seizures
por: Mizoguchi, Hiroyuki, et al.
Publicado: (2013)

Therapeutic Targets for Neurodevelopmental Disorders Emerging from Animal Models with Perinatal Immune Activation
por: Ibi, Daisuke, et al.
Publicado: (2015)

Electroacupuncture attenuates cognition impairment via anti-neuroinflammation in an Alzheimer’s disease animal model
por: Cai, Mudan, et al.
Publicado: (2019)

Innate immune activation of astrocytes impairs neurodevelopment via upregulation of follistatin-like 1 and interferon-induced transmembrane protein 3
por: Yamada, Shinnosuke, et al.
Publicado: (2018)

Brain Representation of Animal and Non-Animal Images in Patients with Mild Cognitive Impairment and Alzheimer’s Disease
por: Marefat, Haniyeh, et al.
Publicado: (2023)

A Review of Selected IBD Biomarkers: From Animal Models to Bedside
por: Mizoguchi, Emiko, et al.
Publicado: (2021)

Improved Diagnostic Multimodal Biomarkers for Alzheimer's Disease and Mild Cognitive Impairment
por: Martínez-Torteya, Antonio, et al.
Publicado: (2015)

Plasma osteopontin as a biomarker of Alzheimer’s disease and vascular cognitive impairment
por: Chai, Yuek Ling, et al.
Publicado: (2021)

Neuroimage Biomarker Identification of the Conversion of Mild Cognitive Impairment to Alzheimer’s Disease
por: Kung, Te-Han, et al.
Publicado: (2021)

Tau as a biomarker of cognitive impairment and neuropsychiatric symptom in Alzheimer's disease
por: Dang, Mingxi, et al.
Publicado: (2022)

CSF Biomarkers in the Early Diagnosis of Mild Cognitive Impairment and Alzheimer’s Disease
por: Papaliagkas, Vasileios, et al.
Publicado: (2023)

Modeling the heterogeneity in risk of progression to Alzheimer's disease across cognitive profiles in mild cognitive impairment
por: Tatsuoka, Curtis, et al.
Publicado: (2013)

Mild cognitive impairment: animal models
por: Pepeu, Giancarlo
Publicado: (2004)

Dual-Model Radiomic Biomarkers Predict Development of Mild Cognitive Impairment Progression to Alzheimer’s Disease
por: Zhou, Hucheng, et al.
Publicado: (2019)

Contribution of Alzheimer's biomarkers and risk factors to cognitive impairment and decline across the Alzheimer's disease continuum
por: Tosun, Duygu, et al.
Publicado: (2021)

Touchscreen-based location discrimination and paired associate learning tasks detect cognitive impairment at an early stage in an App knock-in mouse model of Alzheimer’s disease
por: Saifullah, Md. Ali Bin, et al.
Publicado: (2020)

Metabolomic profiling of CSF and blood serum elucidates general and sex-specific patterns for mild cognitive impairment and Alzheimer’s disease patients
por: Berezhnoy, Georgy, et al.
Publicado: (2023)

Placental Extract Improves Hippocampal Neuronal Loss and Fear Memory Impairment Resulting From Chronic Restraint Stress in Ovariectomized Mice
por: Takuma, Kazuhiro, et al.
Publicado: (2012)

Frontal White Matter Hyperintensity Is Associated with Verbal Aggressiveness in Elderly Women with Alzheimer Disease and Amnestic Mild Cognitive Impairment
por: Ogama, Noriko, et al.
Publicado: (2018)

Resting state EEG biomarkers of cognitive decline associated with Alzheimer’s disease and mild cognitive impairment
por: Meghdadi, Amir H., et al.
Publicado: (2021)

Plasma biomarkers for diagnosis of Alzheimer's disease and prediction of cognitive decline in individuals with mild cognitive impairment
por: Kivisäkk, Pia, et al.
Publicado: (2023)

Experimentally induced animal models for cognitive dysfunction and Alzheimer's disease
por: Rapaka, Deepthi, et al.
Publicado: (2022)

Nonlinear biomarker interactions in conversion from mild cognitive impairment to Alzheimer's disease
por: Popescu, Sebastian G., et al.
Publicado: (2020)

G-CSF rescues the memory impairment of animal models of Alzheimer's disease
por: Tsai, Kuen-Jer, et al.
Publicado: (2007)

Orally Administrated Cinnamon Extract Reduces β-Amyloid Oligomerization and Corrects Cognitive Impairment in Alzheimer's Disease Animal Models
por: Frydman-Marom, Anat, et al.
Publicado: (2011)

Novel Balance Mechanism Participates in Stem Cell Therapy to Alleviate Neuropathology and Cognitive Impairment in Animal Models with Alzheimer’s Disease
por: Qin, Chuan, et al.
Publicado: (2021)

Dietary Protection against Cognitive Impairment, Neuroinflammation and Oxidative Stress in Alzheimer’s Disease Animal Models of Lipopolysaccharide-Induced Inflammation
por: Decandia, Davide, et al.
Publicado: (2023)

Amelioration of Alzheimer’s disease pathology and cognitive deficits by immunomodulatory agents in animal models of Alzheimer’s disease
por: Martinez, Bridget, et al.
Publicado: (2019)

An introduction to therapeutic approaches to vascular cognitive impairment
por: Hainsworth, Atticus H, et al.
Publicado: (2021)

Multimodal MRI Neuroimaging Biomarkers for Cognitive Normal Adults, Amnestic Mild Cognitive Impairment, and Alzheimer's Disease
por: Lin, Ai-Ling, et al.
Publicado: (2012)

Neurogranin as a cognitive biomarker in cerebrospinal fluid and blood exosomes for Alzheimer’s disease and mild cognitive impairment
por: Liu, Weilin, et al.
Publicado: (2020)

Elucidating the role of DEPTOR in Alzheimer’s disease
por: DAVIES, JULIE, et al.
Publicado: (2014)

Impact of frontal white matter hyperintensity on instrumental activities of daily living in elderly women with Alzheimer disease and amnestic mild cognitive impairment
por: Ogama, Noriko, et al.
Publicado: (2017)

Predictive models for mild cognitive impairment to Alzheimer’s disease conversion
por: Skolariki, Konstantina, et al.
Publicado: (2021)

Treatment of cognitive impairment in Alzheimer's disease
por: Burns, Alistair
Publicado: (2003)

Mitochondria, Cognitive Impairment, and Alzheimer's Disease
por: Mancuso, M., et al.
Publicado: (2009)

Nutraceuticals in cognitive impairment and Alzheimer’s disease
por: Mecocci, P., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_2s8u4euoustot01ob8qr86fiu2